Berlin, Germany

Rolf Nuck


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 78(Granted Patents)


Location History:

  • 1000 Berlin 33, DE (1997)
  • Berlin, DE (2004)

Company Filing History:

goldMedal2 out of 832,843 
Other
 patents

Years Active: 1997-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf Nuck: Innovator in Recombinant Glycoproteins

Introduction

Rolf Nuck is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant glycoproteins. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Rolf Nuck's latest patents include innovative methods and products related to recombinant glycoproteins. One of his notable inventions is a method for the production of recombinant glycoproteins that serve as messenger substances and signaling agents in the human circulatory system. This invention encompasses a range of novel recombinant human glycoproteins, including differentiation factors, growth factors, thrombolytic agents, thromboprophylactic agents, coagulation factors, interferons, and interleukins. Additionally, he has developed antibodies against N-glycan structures of cell membrane surfaces, which show positive reactions in ELISA tests against antigenic oligosaccharides.

Career Highlights

Throughout his career, Rolf Nuck has focused on advancing the understanding and application of glycoproteins in medicine. His innovative approaches have led to the development of pharmaceutical agents that utilize these glycoproteins for therapeutic purposes. His work is characterized by a commitment to improving health outcomes through scientific research and innovation.

Collaborations

Rolf Nuck has collaborated with notable colleagues in his field, including Werner Reutter and Rudolf Tauber. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Rolf Nuck's contributions to the field of recombinant glycoproteins exemplify the impact of innovation in biotechnology. His patents and collaborative efforts continue to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…